| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Regeneron Pharmaceuticals, Inc. (REGN) have been net sellers, shedding 8,093 shares worth roughly $6.5M on balance. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
The insider who sold still holds shares after the sale. REGN sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Pres | 310.5K | - | - | |
| CEO | 214.5K | $165.63M | - | |
| Other | 47.8K | $36.05M | -4,147 | |
| VP | 36.4K | $30.20M | - | |
| Dir | 31.0K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 14, 2026 | Murphy Andrew J54 | Co-chief Scientific Officer | Sale+OE10b5-1 | 4,147 | $772.70 | $3,204,375.76 | -8.0% | - | - | |
| Sep 3, 2026 | McCourt Marion55 | EVP Commercial | Sell10b5-1 | 2,346 | $853.56 | $2,002,458.09 | -16.3% | - | - | |
| Sep 2, 2026 | Guarini Kathryn | Director | Sale+OE10b5-1 | 400 | $850.00 | $340,000.00 | -39.9% | - | - | |
| Aug 10, 2026 | Guarini Kathryn | Director | Sale+OE10b5-1 | 400 | $800.00 | $320,000.00 | -39.9% | - | - | |
| Aug 10, 2026 | Zoghbi Huda Y | Director | Sale+OE10b5-1 | 800 | $800.00 | $640,000.00 | -32.0% | - | - | |
| Jul 2, 2026 | Ryan Arthur F54 | Director | Sell10b5-1 | 200 | $650.15 | $130,030.00 | -1.1% | +15.9% | - | |
| May 1, 2026 | Ryan Arthur F54 | Director | Sell10b5-1 | 100 | $705.24 | $70,523.80 | -0.6% | +5.3% | - | |
| Apr 1, 2026 | Ryan Arthur F54 | Director | Sell10b5-1 | 100 | $777.27 | $77,727.28 | -0.6% | -19.8% | - | |
| Mar 2, 2026 | Ryan Arthur F54 | Director | Sell10b5-1 | 100 | $785.50 | $78,549.55 | -0.6% | -24.0% | - | |
| Feb 19, 2026 | Zoghbi Huda Y | Director | Sale+OE10b5-1 | 1,638 | $781.33 | $1,279,811.86 | -49.0% | -17.0% | - |